On December 11, Guolonghui reported that Shanghai Shyndec Pharmaceutical (600420.SH) announced that its holding subsidiary, China National Pharmaceutical Group Zhijun (Shenzhen) Pharmaceutical Co., Ltd., received the drug registration certificate for Cefoperazone Ester Tablets approved and issued by the National Medical Products Administration. Cefoperazone Ester Tablets are oral third-generation cephalosporin antibiotics, effective against both Gram-positive and Gram-negative bacteria. They are used to treat upper respiratory infections, lower respiratory infections, uncomplicated urinary tract infections, uncomplicated skin and soft tissue infections, acute uncomplicated gonococcal urethritis and cervicitis, and perianal infections caused by Neisseria gonorrhoeae, among others.